CSIMarket
 
Cvs Health Corporation  (CVS)
Other Ticker:  
 
 
Price: $53.6700 $0.04 0.075%
Day's High: $53.35 Week Perf: -6.56 %
Day's Low: $ 52.77 30 Day Perf: -20.43 %
Volume (M): 2,047 52 Wk High: $ 83.25
Volume (M$): $ 108,879 52 Wk Avg: $70.93
Open: $55.38 52 Wk Low: $52.77



 Market Capitalization (Millions $) 68,000
 Shares Outstanding (Millions) 1,267
 Employees 300,000
 Revenues (TTM) (Millions $) 360,935
 Net Income (TTM) (Millions $) 7,350
 Cash Flow (TTM) (Millions $) -4,848
 Capital Exp. (TTM) (Millions $) 2,752

Cvs Health Corporation
CVS Corporation is a leader in the retail drugstore industry in the United States with net sales of $26.6 billion in 2003, making us the second largest retail drugstore chain based on sales. We operate 4,179 retail and specialty pharmacy stores in 32 states and the District of Columbia. We currently operate in 68 of the top 100 U.S. drugstore markets and hold the number one market share in 32 of these markets. Overall, we hold the number one or number two market share in 62% of the markets in which we operate.


   Company Address: One CVS Drive, Woonsocket, 2895 RI
   Company Phone Number: 765-1500   Stock Exchange / Ticker: NYSE CVS
   


Customers Net Income fell by CVS's Customers Net Profit Margin fell to

-50.46 %

2.19 %

• Customers Performance • Customers Expend. • Customers Efficiency • List of Customers


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Cvs Health Corporation

CVS Health Corporation's Revenue Growth Surges, but Earnings Dip in Q1 2024

CVS Health Corporation, a leading healthcare company, has reported its financial results for the first quarter of 2024. Despite an increase in revenue, the company disclosed a decline in earnings per share (EPS). Revenue grew by 3.704% to $88.44 billion compared to $85.28 billion in the same period last year. However, net profit per share plummeted by -46.67% to $0.88 per share, compared to $1.65 per share in the corresponding period a year ago.
Although CVS's revenue growth was below that of its peers in the Pharmacy Services & Retail Drugstore industry, it still reported a 12.76% improvement compared to the same period last year. In the previous reporting period, CVS Health Corporation achieved revenue of $93.81 billion and bottom line earnings of $1.59 per share. However, in the first quarter of 2024, earnings fell by -47.53% to $1,124.000 million from $2,142.000 million in the same period a year before.

Contract

Aetna Better Health of Michigan Secures CHCP Contract Recommendation amid CVS Health's Notable Revenue Acceleration

Published Tue, Apr 9 2024 4:00 PM UTC

Aetna Better Health of Michigan Scores CHCP Contract Recommendation; CVS Health Sees Revenue SurgeSOUTHFIELD, Mich., April 9, 2024 ?? An important update from the health sector emphasizes the remarkable progress made by Aetna Better Health of Michigan, a CVS Health company (NYSE: CVS), and its parent corporation, CVS Health. The Michigan Department of Health and Human Servic...

Cvs Health Corporation

CVS Health Corporation Sees Decrease in Fourth Quarter 2023 Earnings Amidst Impressive Revenue Growth

CVS Health Corporation, a leading Pharmacy Services & Retail Drugstore company, experienced a slight decline in its shares during the month of February 2024. The shares dropped by -0.22%, bringing the year-to-date performance to -8.77%. Currently trading on the NYSE, CVS Health Corporation's shares are valued at 1% above its 52-week average.
During the period from October to December 2023, CVS Health Corporation witnessed a reduction in its earnings per share (EPS) despite a significant increase in revenue. The profitability decreased by -9.26% to $1.59 per share, while the revenue grew extensively by 11.887% to $93.81 billion compared to the same period the previous year. This growth in revenue outpaced the top-line performance of most other companies in the Pharmacy Services & Retail Drugstore sector, as they reported an average revenue advance of 11.61% in the fourth quarter of 2023 compared to the previous year.

Cvs Health Corporation

CVS Health Corporation emerges as industry leader with impressive revenue growth in Q3 2023

CVS Health Corporation, a leading player in the Pharmacy Services & Retail Drugstore sector, has bucked the trend of declining orders and fading revenue that has plagued many companies in the industry. In its fiscal third quarter of 2023, the company reported positive profits of $1.75 per share, a significant improvement from the loss of $2.60 per share in the same period last year. This represents a commendable turnaround for CVS Health Corporation.
Net profit per share also saw a healthy increase of 18.24% from the prior financial reporting period, reaching $1.48 per share. Additionally, the company witnessed a notable growth of 10.603% in revenue, which amounted to $89.76 billion compared to $81.16 billion in the corresponding period a year ago. Sequentially, revenue advanced slightly by 0.948% from $88.92 billion.

Cvs Health Corporation

CVS Health Corporation Witnesses Noteworthy EPS Decline Amid Enhanced Revenue Performance in Q2 2023, Despite Outpacing Pharmacy Services & Retail Drugstore Industry

As a stock market journalist, I have been closely following the financial results of CVS Health Corporation. In the second quarter of 2023, CVS experienced a reduction in earnings per share (EPS) despite a respectable growth in revenue. The net profit per share dropped by -33.63% to $1.48 per share, while revenue increased by 10.275% to $88.92 billion compared to the same quarter last year.
However, it is important to note that CVS Health Corporation has managed to outperform its industry contemporaries in terms of revenue growth. While the Pharmacy Services & Retail Drugstore industry showed a 9.87% revenue growth during the same period, CVS saw a higher growth rate of 10.275%. This signifies the company's success in generating robust top-line figures.






 

Cvs Health's Segments
 
Retail Pharmacy
 Segment     of total Revenue
PBM
 Segment     of total Revenue
PBM Mail choice
 Segment     of total Revenue
PBM Pharmacy network
 Segment     of total Revenue
PBM Other
 Segment     of total Revenue
 
• View Complete Report

Cvs Health's Operating Statistics Decrease / Increase
       
Mail choice claims processed (millions)    Mail choice claims processed (millions) Growth   
Pharmacy network claims processed (millions)   Pharmacy network claims processed (millions) Decline   
Pharmacy claims processed (millions)   Pharmacy claims processed (millions) Decline   
Avg. Rev. Per Mail choice claim ($)   Avg. Rev. Per Mail choice claim ($) Decline   
Avg. Rev. Per Network claim ($)    Avg. Rev. Per Network claim ($) Growth   
Retail prescriptions filled (millions)     
Retail drugstores operated    Retail drugstores operated Growth   
Avg. Rev. Per Retail drugstore (thousands $)    Avg. Rev. Per Retail drugstore (thousands $) Growth   




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com